International Monetary Fund boss Christine Lagarde is being investigated by French prosecutors regarding a rare and minor charge of negligence in the use of public funds
The bidder's chief executive said he won't take no for an answer, and Dollar General's quarterly results show why
The law says campaigns and interest groups can’t coordinate, but that doesn’t stop them
A few years ago, big media companies were filing copyright lawsuits against YouTube. Now they’re buying in
There is increasing government and market scrutiny on for-profit schools, whose business model depends on enrollment
Chermayeff & Geismar has designed some of the most memorable corporate identities. But you may not have heard of them
At 56, the Purple One is fantastic in concert, but he hasn't made a really good album in years
Expenses surrounding cover-ups, legal counsel and support services can reach into the millions when sexual abuse scandals roil campuses, and insurance companies are obliging with new policies.
The St. Louis suburb's businesses face enormous challenges
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."